Day: January 31, 2013

  • DePuy Executive Asked Why Plans to Re-Design ASR Hip Halted

    The president of the orthopedic division of Johnson & Johnson, Andrew Ekdahl, said the company recalled their all-metal implant due to it not meeting “clinical needs for the product.” He testified at a trial recently due to claims the company failed to issue warnings about the risks involved with the implants. He was questioned by […]

  • Executive’s Involvement with Defective Hip Implant Questioned

    A new executive was hired to lead Johnson & Johnson’s orthopedics division after the company’s artificial hip implants were recalled in an effort to help clear their image. However, the executive who was hired knew about the defects three years before the implants were recalled and supervised the introduction of the implant in the US. […]